Answers are grounded in this paper and cite their sources.
These laboratory-confirmed cases of botulism demonstrate that clinical use of unlicensed botulinum toxin A can result in severe, life-threatening illness. Further education and regulation are needed to prevent the inappropriate marketing, sale, and clinical use of unlicensed botulinum toxin products.
No takes yet. Share an insight, caveat, or question.
Chertow et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: